The Grx (glutaredoxin) proteins are oxidoreductases with a central function in maintaining the redox balance within the cell. In the present study, we have explored the reactions between selenium compounds and the glutaredoxin system. Selenite, GSSe-SG (selenodiglutathione) and selenocystine were all shown to be substrates of human Grx1, implying a novel role for the glutaredoxins in selenium metabolism. During the past few years, selenium has further evolved as a potential therapeutic agent in cancer treatment, and a leading mechanism of cytotoxicity is the generation of ROS (reactive oxygen species). Both selenite and GS-Se-SG were reduced by Grx1 and Grx2 in a nonstoichiometric manner due to redox cycling with oxygen, which in turn generated ROS. The role of Grx in selenium toxicity was therefore explored. Cells were treated with the selenium compounds in combination with transient overexpression of, or small interfering RNA against, Grx1. The results demonstrated an increased viability of the cells during silencing of Grx1, indicating that Grx1 is contributing to selenium toxicity. This is in contrast with TrxR (thioredoxin reductase), which previously was shown to protect cells from selenium cytotoxicity, verifying a diverse role between Grx and TrxR in selenium-mediated cytotoxicity. Furthermore, selenium treatment led to a marked increase in protein glutathionylation and cysteinylation that potentially can influence the activity and function of several proteins within the cell.
INTRODUCTION
Selenium compounds are known to decrease cell proliferation, cause DNA fragmentation and induce apoptosis in tumour cells at high concentrations [1] . Previous studies have also shown a high degree of selectivity towards malignant cells, where treatment with selenite (SeO 3 2− ) demonstrated 80 % cell death in primary malignant mesothelioma cells, whereas equimolar concentrations of selenite in the corresponding normal cells only had marginal effects [2] . For patient-matched pairs of primary normal and malignant prostate cells, selenite selectively killed the cancer cells, leaving the normal cells virtually unaffected [3] . One mechanism behind cancer-specific cytotoxicity of selenite may be specific high uptake and accumulation in malignant cells due to an abnormal highly reduced extracellular environment, possibly connected to drug resistance [4] . In the intracellular environment, reduced selenium in the form of selenide (RSe − , HSe − ), undergoes redox cycling with oxygen and thiols, causing a rapid and massive non-stoichiometric ROS (reactive oxygen species) production [5, 6] . Unbalanced generation of ROS, such as superoxide, can in turn damage cellular constituents and consequently induce apoptosis [7] . The apoptotic response varies between different selenium compounds, but is generally a caspase-dependent process [8] . Selenium compounds therefore have been suggested as potent novel cytotoxic agents [9, 10] . Redox-active selenium compounds are metabolized by GSH and the Trx (thioredoxin) system. In these reactions, HSe − is formed for the synthesis of selenoproteins [11] .
Grx (glutaredoxin) proteins are redox-active proteins present in almost all living organisms [12] . In humans, four glutaredoxins are presently known: Grx1, Grx2, Grx3 and Grx5 [13, 14] . Grxs catalyse glutathione disulfide oxidoreductions via their active site, which consists of two redox-active cysteine residues. The glutaredoxin system is a coupled system composed of GSH and GR (glutathione reductase) with NADPH as the source of reducing equivalents [12] . The activity of Grx is pH dependent as well as strongly affected by the intracellular redox state and, more specifically, by the glutathione ratio (GSSG/GSH), which is the superior thiol buffer in the cell [15] [16] [17] [18] [19] . The oxidoreductions are either dithiol reactions with protein disulfides or monothiol reactions of mixed disulfides with GSH. The monothiol mechanism involves the ability to couple/uncouple protein cysteines with glutathione, a process known as glutathionylation/deglutathionylation [20, 21] . Glutathionylation is rising in importance as a key post-translational alteration, responsible for transducing oxidant signals and functioning as a sensor for the cellular redox balance [22, 23] . While protecting the cells from oxidative stress and maintaining the general redox balance, they are also involved in several other cellular functions, such as DNA synthesis [24] , regulation of transcription factors [25, 26] , regulation of cellular iron, including iron-cluster biogenesis [27] , and apoptosis [28] . Grx has also been implicated in cancer with a clear up-regulation in several tumours [9, [29] [30] [31] .
The contribution of Grxs in selenium metabolism and cytotoxicity is largely unknown. Being a highly redox-active protein catalysing the reduction of disulfides and/or mixed disulfides makes Grx an ideal candidate. In the present study, we have used both pure in vitro systems and cell experiments to elucidate the role of glutaredoxins in selenium metabolism and toxicity.
EXPERIMENTAL

Materials
PEST (penicillin/streptomycin) and RPMI 1640 medium were obtained from Invitrogen. Sodium selenite (Na 2 SeO 3 ), Se-DL-cystine (seleno-DL-cystine), DL-cystine, dithiothreitol, Hepes, BSA, GSH, GR, BSO (buthionine sulfoximine) and NADPH were all purchased from Sigma-Alrich. GSSe-SG (selenodiglutathione) was obtained from PharmaSe. Thiolyte ® MBB (monobromobimane) reagent was purchased from Calbiochem. Escherichia coli Grx1, Grx1C14S, Grx3C65Y and Grx3C14S/C65Y, were a gift from Dr Alexios VlamisGardikas. Recombinant human Grx1 and the specific anti-Grx1 antibody were obtained from IMCO, and recombinant Grx2 was purchased from Histo-Line Laboratories.
Grx activity
The Grx activity was determined as described previously [32] by measuring the reduction of 0.7 mM HED (2-hydroxyethyl disulfide). A fresh mixture of 1 mM GSH, 0.2 mM NADPH, 2 mM EDTA, 0.1 mg/ml BSA and 6 μg/ml yeast GR was prepared in 100 mM Tris/HCl, 2 mM EDTA, pH 8.0.
The activity was determined by the oxidation of NADPH monitored at A 340 using a molar extinction coefficient of 6200
Measurements of selenium compounds as substrates were performed under identical conditions, but with the replacement of HED by the selenium or sulfur compound tested. The assay was adapted to a 96-well plate with a final volume of 100 μl of the reaction mix. For selenite, the GSH content of the mixture was reduced to 50 μM to achieve a minimal background and thereby enable monitoring of the reaction.
Superoxide production
Mitochondrial superoxide production mediated by selenium treatment was measured by MitoSOX TM Red mitochondrial superoxide indicator from Invitrogen. Briefly, cells were seeded on to slides (+) and incubated for 24 h following treatment with selenium compounds for 4 h. Staining of cells was performed according to the manufacturer's instructions. A Leica DM IRBE fluorescence microscope was used for ROS detection, and pictures were captured and analysed with OpenLab5 (Improvision) and Volocity 5 software.
Cell line and cell culture
Experiments were performed using the well-established human large-cell lung carcinoma line H-157. Cells were grown in 75 cm 2 Sarstedt culture flasks with RPMI 1640 medium supplemented with 10 % (v/v) fetal bovine serum, without antibiotics added to the medium, at 37
• C and 5% CO 2 . Prior to treatment, cell confluence was assessed by light microscopy and adjusted to approx. 70-80 %, and upon treatment, the culture medium was exchanged with fresh medium prepared with different xenobiotics.
Viability assay
Cell viability was performed using the Cell Proliferation Kit II (XTT; Roche) as described in the manufacturer's instructions.
In brief, cells were seeded in 96-well cell-culture plates and left to adhere overnight prior to treatment. Upon treatment, the medium was replaced with 100 μl of fresh medium containing the xenobiotic of choice and incubated for an additional 20 h. The A 490 was measured in a PowerWave TM HT microplate spectrophotometer (BioTek) with the reference, A 650 , subtracted. Each sample was used in octuplicate and the experiment was repeated three times.
Transfection
Transient overexpression of Grx1 was performed with the pIRES/Grx-vector [33] and the empty pIRES control-vector, both gifts from Dr Angel Cedazo-Minguez, Novum, Karolinska Institutet, Stockholm, Sweden. The plasmids were amplified in E. coli TOP10F competent cells, extracted and purified using the Qiagen Plasmid Midi Kit. H-157 cells were seeded into a six-well plate in 2.5 ml of growth medium and incubated for 24 h. Cells were transfected with 1 μg of plasmid using 3 μl of Lipofectamine TM 2000 (Invitrogen), pre-diluted in OptiMEM1, following the instructions provided by the manufacturer. To reduce cell death, the transfection reagent was removed after 4-6 h, and the cells were washed with PBS prior to the addition of fresh medium. On the following day, cells were treated with selected selenium compounds for 24 h.
Three different commercial Grx1 siRNA (small interfering RNA) primers (109163, 10839 and 117030) were initially used for optimization, together with a scrambled primer with randomized nucleotides as a control (all from Ambion). By analysing suppression of the Grx1 mRNA level after 24 h, we determined primer 3 (117030) was the most effective and hence was our choice of construct in all experiments. H-157 cells were seeded into six-well or 96-well plates and directly transfected with 10 nM siRNA using 3 μl of NeoFX (Ambion) as a transfection reagent. All components were pre-diluted in OptiMEM1 (Invitrogen), and incubated for 24 h. The cell viability was not affected by the transfection with scrambled siRNA.
Preparation of total cell extracts
Cell pellets stored for enzymatic analysis were dissolved in cold PBS. The cells were sonicated at 40 W using three pulses of 5 s (Vibra-Cell TM ; Sonics & Materials). The supernatants were cleared by centrifugation at 25 200 g for 30 min at 2
• C. Total protein concentration was determined by the Bradford method as described in the manufacturer's instructions (Bio-Rad Laboratories).
RNA extraction
Total RNA extraction was performed as decribed in the RNeasy Plus Mini Kit protocol (Qiagen), with on-column DNase digestion. RNA was quantified using a NanoDrop ® ND-1000 spectrophotometer. Synthesis of cDNA was performed through reverse transcription using the the Omniscript Reverse Transcription Kit protocol with 2 μg of RNA and 0.1 μg/μl oligo (dT) 12−18 as the primer.
qPCR (quantitative PCR)
qPCR was performed on a Bio-Rad iCycler with 20 ng of cDNA per reaction in triplicates on 96-well plates using Platinum SYBR Green qPCR Super Mix (Invitrogen). The final volume for each reaction was 25 μl. The qPCR programme, including primers and concentrations, was performed using the method of Olm et al. [9] . Results were analysed using the 2 
Figure 1 Selenium compounds as substrates for human Grx
The reaction was performed in TE (Tris/EDTA) buffer containing, 200 μM NADPH, 6 μg/ml GR and 1 mM GSH (the reaction with selenite (A) contained 50 μM GSH). All reactions were performed with 1 μM Grx1 in the sample cuvette and with an equal volume of TE buffer in the reference cuvette. The specific selenium compound, at various concentrations, was added into both the sample and reference cuvette and the reactions were initiated by the addition of Grx1. The background reaction was subtracted. NADPH consumption was monitored at A 340 . (A) Selenite, (B) GS-Se-SG, (C) Se-DL-cystine and (D) DL-cystine.
cut-off was set to 32 cycles. The efficiencies of the different primer sets were 95 + − 5 %.
ELISA for Grx1
The assay was performed using the method of Lundberg et al. [34] with some minor modifications. All steps were performed in a volume of 50 μl. The primary antibody (2 μg/ml) was diluted in carbonate buffer, pH 9.6, and plates were coated overnight at 4
• C. The secondary biotinylated antibody was added at a concentration of 1 μg/ml. A 405 was measured using a PowerWave TM HT microplate spectrophotometer (BioTek). Data were analysed by Gen 5 software (BioTek).
Glutathione depletion
To deplete cells of glutathione, cells were treated for 24 h with 100 nM BSO prior to treatment.
Glutathione and cysteine determination
Samples for measurements of intracellular cysteine/cystine and GSH/GSSG levels were prepared as described by Cotgreave and Moldeus [35] and analysed by the modified protocol by Luo et al. [36] .
Statistical analysis
Statistical analysis was performed for determination of significance, using a Wilcoxon matched-pairs test. For the analysis, Statistica software (StatSoft Scandinavia AB) was used.
RESULTS
Selenium compounds are substrates of Grxs
In order to investigate whether Grx reduced selenium compounds, the specific activity of Grx was measured with various concentrations of selenite, GS-Se-SG, Se-DL-cystine and its sulfur analogue DL-cystine. The reaction was initiated by the addition of Grx, and NADPH consumption was monitored for 4 min. Grx1 reduced all substrates in a concentration-dependent manner as shown in Figure 1 , where the background reaction of GSH is subtracted. Although the reaction was stoichiometric with Se-DL-cystine and DL-cystine ( Figures 1C and 1D) , the NADPH consumption with selenite and GS-Se-SG ( Figures 1A  and 1B) continued beyond stoichiometric reduction, probably to selenide, caused by concomitant redox cycling with oxygen. The background reaction of the various compounds is illustrated in Figure 2 (A), together with the reaction rate after addition of 1 μM Grx1. In order to detect superoxide and to investigate possible variations in ROS production caused by the different compounds ( Figure 2B) , the cell line H-157 was treated for 4 h with selenite, GS-Se-SG and Se-DL-cystine at IC 50 concentrations prior to staining. Selenite and GS-Se-SG clearly triggered superoxide production, whereas Se-DL-cystine did not. This also supports the in vitro findings where no redox cycling with oxygen could be observed for Se-DL-cystine. Similar to Grx1, Grx2 also reduced GS-Se-SG ( Figure 3A ) in a concentration-dependent manner. The reduction by Grx1 and Grx2 was also dependent on the concentration of Grx ( Figures 3B and 3C) , with the two proteins exhibiting similar reducing capacities. The activity of the human Grx1 was further compared with E. coli Grx1 and Grx3(C65Y), with similar activity observed between the two species (Table 1) . To further study the mechanisms of Grx-mediated reduction of selenium, E. coli Grx mutants were used. Two Grx mutants lacking the second cysteine residue in the active site, enabling them only to reduce mixed disulfides with GSH [Grx1(C14S) and Grx3(C14S/C65Y)] were used to distinguish between the two catalytic mechanisms of Grx, i.e. the monothiol and the dithiol. The NADPH consumption and activity was almost identical for the wildtype and the active-site mutants, demonstrating a monothiol reaction mechanism for the reduction of the selenium compounds (Table 1) . 
Differential toxicity among various selenium species
The IC 50 for GS-Se-SG, selenite, selenate, Se-DL-cystine and DLcystine were investigated using the cell line H-157 derived from human lung cancer. GS-Se-SG was the most cytotoxic compound with an IC 50 of 3.5 μM, followed by selenite at 4.5 μM and Se-DLcystine at 100 μM (Table 2 ) after 24 h of incubation. The sulfur
Figure 4 Grx levels in selenite-treated lung cancer cells
The cell line H-157 was treated with selenite over a period of 48 h. Cells were harvested and analysed after 24, 28 and 48 h of treatment. mRNA levels of (A) Grx1 and (B) Grx2 were measured using qPCR.
(C) The specific Grx activity was measured with the HED assay, and (D) Grx1 protein levels were detected by specific sandwich ELISA. Results are means + − S.E.M. of three independent experiments. Statistical analysis was performed by the Wilcoxon matched-pairs test (** p < 0.01 * p < 0.05). Grx1as, alternatively spliced Grx1. analogues sulphite and sulphate that were also tested were at least 50-fold less toxic (results not shown).
Selenite induces expression of glutaredoxins
To explore the effects of selenite on glutaredoxins, H-157 cells were treated with 5 μM selenite over a period of 48 h. RNA and protein fractions were collected at different time points for both treated and untreated cells. Grx1 and Grx2 mRNA levels ( Figures 4A and 4B ), specific activities ( Figure 4C ) and Grx1 protein levels ( Figure 4D ) were up-regulated at all time points examined. The mRNA levels for Grx1, Grx1as (alternatively spliced Grx1) and Grx2b increased markedly (20-60-fold) after treatment compared with the control for up to 28 h of incubation, while Grx1 continued to increase even at 48 h. All other Grx variants decreased after 48 h. In the same manner, levels of Grx1 protein increased over time ( Figure 4D ), as well as the amount of active protein, compared with the untreated cells ( Figure 4C ).
Grx1 has a role in selenium cytotoxicity
To investigate the role of Grx1 in selenium cytotoxicity Grx1 levels in H-157 cells were altered by either siRNA or by transient overexpression. After optimization of conditions for knockdown of the gene, a decrease of Grx1 activity to 30 % of normal after 24 h, and 40 % after 48 h, was accomplished ( Figure 5A ). The overexpression of Grx1 resulted in an increase of the protein content of 16-fold at 24 h and 25-fold after 48 h, analysed by ELISA ( Figure 5B ). Transfected cells were treated with selenite, GS-Se-SG or Se-DL-cystine and viability was compared with mock-treated cells (Grx1-siRNA/scrambled, Grx1-vector/empty vector) respectively. Selenium treatment in combination with suppression of Grx1 resulted in a significant decreased cytotoxicity for all selenium compounds investigated ( Figure 5A ). In contrast, overexpression with Grx1 showed a tendency towards a slightly increased, although not statistically significant, cytotoxicity ( Figure 5B ).
Glutathione depletion sensitizes cells to selenite
Glutathione in H-157 cells was depleted for 24 h by BSO, which resulted in a greater than 90 % reduction of total GSH levels, while cysteine levels remained intact (results not shown). The remaining pool of glutathione in BSO-treated cells was approx. 10 % more oxidized compared with control cells, whereas the cysteine/cystine ratio had a 10 % shift towards the reduced pool (results not shown). Cells treated with selenite in combination with a pretreatment with BSO were significantly more sensitive to selenite ( Figure 6A ) compared with control cells. BSO had no intrinsic effect on viability. 
Selenite treatment increases protein-bound glutathione and cysteine levels
Intracellular glutathione and cysteine levels were determined by HPLC after 5 h of incubation with 5 μM selenite, and compared with untreated cells ( Figure 6B ). The total levels of cysteine increased by 70 % after treatment with 5 μM selenite, whereas glutathione remained unchanged. The oxidized form of both cysteine and glutathione increased after selenite treatment by approx. 65 % and 30 % respectively, resulting in a redox shift to a more oxidizing ratio (cysteine/cystine and GSH/GSSG). Proteinbound cysteine and glutathione markedly changed, with a 5-fold increase, compared with untreated cells. Suppression of Grx1 with siRNA did not influence the results notably (results not shown).
DISCUSSION
Selenium compounds are known to generate ROS and cause oxidative stress, which in turn may cause cellular damage. The glutaredoxin system is one central cellular defence system that protects against oxidative stress by maintaining the redox balance within the cell through the reduction of thiols. As the mechanism behind selenium cytotoxicity has not been thoroughly explored, we aimed to study the interaction between selenium compounds and the Grx system. Selenite, GS-Se-SG, Se-DL-cystine and DL-cystine were all shown to be substrates of Grx1. The reduction of the selenium compounds implies a novel and important role for the glutaredoxins in selenium metabolism [10] . The reduction of selenite and GS-Se-SG is a significant step in selenium metabolism, enabling the incorporation of selenium into selenoproteins. Even though this step can be carried out by GSH, GSH is far less reactive with the selenium compounds in comparison with Grx. By comparing the oxidation of NADPH, however, it is clear that the reaction of the Trx system is more efficient than the Grx system in the reduction of GS-Se-SG in vitro [37] . Selenite, on the other hand, is more readily reduced by the Grx system. The high efficiency of TrxR (Trx reductase) can in all likelihood be addressed to the more redox-active selenocysteine in the active site of TrxR, where a mutation at this site markedly affects the catalytic activity of TrxR [31, 38] . In addition, a modified Grx consisting of a selenocysteine in place of the redox-active cysteine exhibited an almost 2-fold increased specific activity in the catalysis of thiol-disulfide exchange reactions [39] . The efficiency in vivo may also vary between the systems, depending on the redox state of the cell. Nevertheless, our data, in combination with previous results [37] , clearly demonstrate that both of the leading redox systems in the cell are involved in selenium metabolism.
Incubation of selenite and GS-Se-SG with Grx led to a nonstoichiometric oxidation of NADPH, indicating the formation of HSe − and redox cycling with oxygen and ROS formation as illustrated in Figure 7 (A). Redox cycles of HSe − and oxygen have previously been demonstrated by mammalian TrxR and the Trx system [37] . Similar to the Trx system, the initial reaction of Grx1 with selenite and GS-Se-SG was rapid, followed by a slightly slower reaction. The initial oxidation of stoichiometric amounts of NADPH is consistent with the cleavage of the compound, followed by the latter non-stoichiometrical continous reaction. In contrast, Se-DL-cystine and DL-cystine were reduced by Grx1 stoichiometrically with a 1:1 oxidation of NADPH, indicating complete reduction of the compounds. The superoxide production seen after treatment with selenite and GS-Se-SG was also absent in cells treated with Se-DL-cystine, indicating that Se-DL-cystine exerts its cytotoxic effects through a different pathway, which is mediated by other mechanisms not directly involving ROS production.
It has been proposed that selenocystine as well as cystine instead will redox-cycle with intracellular thiols to make new S-S bridges with proteins (intracellular thiols) [40] . Selenocystine may also be randomly incorporated in the place of cysteine ( Figure 7B ). This may affect the tertiary structures and active sites of redox enzymes [41] .
Glutaredoxins are able to catalyse the reduction of proteins and low-molecular-mass substrates via a monothiol or a dithiol mechanism [12] . By comparing glutaredoxins with mutations in the active site and/or GSH-binding site [42] , we examined the mechanism by which GS-Se-SG was reduced. However, no difference was seen when the NADPH consumptions were monitored, confirming that GS-Se-SG was reduced by Grx through the monothiol mechanism.
When the selenium and sulfur compounds were investigated in terms of cytotoxicity, GS-Se-SG proved to be the most potent, closely followed by selenite. Both selenite and selenate were more toxic than their sulfur analogues, implying that the highly reactive selenium atom causes the more pronounced toxic effects [11, 43] . The results further support the hypothesis that growth inhibition and cell death caused by selenium compounds is mediated via the more redox-active forms, such as selenite and GS-Se-SG.
To further investigate the influence of selenium on Grx, the lung cancer cell line H-157 was treated with selenite for 48 h, and both mRNA and protein were extracted. Protein levels, as well as protein activity and mRNA levels, for both Grx1 and Grx2 increased over time after treatment compared with untreated controls. Both protein level and protein activity increased equally over time, which suggests that selenite does not decrease the protein synthesis of Grx1, nor inhibit the activity. The induction of translation and transcription of Grx is most likely due to the oxidizing effects of selenite and the redox-sensory role of the glutaredoxins [44] . The effect of selenium compounds after suppressing Grx1 with siRNA increased the cell viability with up to 20 % compared with control cells (scrambled siRNA). In addition, the opposite trend was seen when cells overexpressing Grx1 followed by the same selenium treatment, implying that Grx1 contributes to selenium cytotoxicity. As the other Grxs are still present in the cell, in particular the proposed tumour-specific Grx2c located in the cytosol, the effect of Grx1 might be less apparent as it has similar properties to Grx2c. The increased viability after suppression of Grx1 might be explained by the diminished redox-cycling of Grx with these compounds, generating less mixed disulfides and ROS. Grx might also contribute to selenium cytotoxicity by the reduction of cystine to cysteine intracellularly and through this mechanism contribute to a more efficient uptake and consequently a higher cytotoxicity [4] . In addition, the mode of catalysis by Grx is dependent upon the redox environment, where Grx can act as a glutathionylating protein under oxidizing conditions and as a deglutathionylating protein when oxidative stress subsides [23] . Our results showing several-fold increases in cysteinylated and glutathionylated proteins upon selenium treatment are remarkable and may be an important mechanism in the toxicity of selenium.
In a previous publication, cells treated with the specific organogold inhibitor Auranofin for suppression of TrxR showed a pronounced sensitization to selenite as demonstrated by decreased viability [45] . Furthermore, TrxR overexpression leads to a pronounced increase in the tolerance to selenite [46] . As a result, TrxR, in contrast with Grx, provides a protective role of the cells against selenium-mediated cytotoxicity, showing a diverse role between the two systems.
Many mechanisms have been suggested for the cytotoxic effects of selenite. In the present study, we demonstrate that the glutaredoxin system reduces selenium compounds in vitro, enabling redox-cycling with oxygen, generating ROS and thereby contributing to the toxic effects observed by redox-active selenium compounds. This study thus reveals a novel function of the glutaredoxins in the selenium metabolism pathway.
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